Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Dravet syndrome

Dravet syndrome

Part of Epilepsy

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Dravet syndrome

10 trials tracked for Dravet syndrome: 7 in phase 3 or 4 and 6 with published results. The most-cited published study has 1653 citations.

10Trials tracked
7Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 3 7 Phase 2 3
  1. Phase 3 Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1) Completed · 1,653 cited
  2. Phase 3 A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome Completed · 363 cited
  3. Phase 3 GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome Completed · 261 cited
  4. Phase 3 A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome Completed · 238 cited
  5. Phase 3 An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes Completed · 107 cited
  6. Phase 3 An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome Completed · 80 cited
Show 4 more trials
  1. Phase 3 A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome Completed
  2. Phase 2 A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1) Completed
  3. Phase 2 Verapamil as Therapy for Children and Young Adults With Dravet Syndrome Completed
  4. Phase 2 A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Systemic inflammatory indices are elevated in pediatric drug-resistant epilepsy versus self-limited epilepsy with centrotemporal spikes
Neurology Cohort
Systemic inflammatory indices are elevated in pediatric drug-resistant epilepsy versus self-limited epilepsy with centrotemporal spikes Are inflammation markers higher in children with hard-to-treat epilepsy than those with self-limited cases?
This real-world cohort study of 140 pediatric patients compared systemic inflammatory indices (NLR, SII, CRP) between those with drug-resist…
Children with hard-to-treat epilepsy show higher blood inflammation markers than those with self-limited cases, though the exact link to bra…
Frontiers Apr 15, 2026
Genetic mutations in febrile sensitivity epilepsy correlate with earlier onset and specific diagnoses in children
Neurology Cohort
Genetic mutations in febrile sensitivity epilepsy correlate with earlier onset and specific diagnoses in children Fever-Triggered Seizures in Children Trace Back to Specific Genes
This retrospective cohort study examined 30 gene-positive cases and 31 gene-negative controls at Wuxi Children's Hospital.
Half of children with fever-triggered seizures carry specific gene mutations that help doctors predict which treatments will work and which …
Frontiers Apr 14, 2026